As shown in Figures 5A,B, cutaneous Curdlan application was associated with a modulation of the IFN-/IL-4 ratios at day 10 and 28, indicating a shift toward a pronounced Th1 and a dampened Th2 response at day 28 after infection (Figure 5C). The gene discussed is IFNA1; the disease is infection.